fda warning compounded semaglutide october 2025 alerts health care providers, compounders and patients of dosing errors associated with injectable products FDA issued 25 warning letters

Regular thyroid stimulating hormone (TSH) testing helps identify whether dose changes are needed, ensuring stable thyroid control throughout GLP-1 therapy

A pharmacy that excels at compounding topical creams or oral capsules may lack the specialized clean-room infrastructure, lyophilization equipment, and analytical testing capabilities required for injectable peptide production

Evidence Linking GLP-1 Agonists to Pancreatitis Risk The evidence regarding GLP-1 agonists and pancreatitis risk remains complex and somewhat contradictory , with different studies yielding varying conclusions

No, you should not take semaglutide and tirzepatide together

Oxygen is necessary for life, but as with everything in life, there is a tradeoff